3 completed, 2 active not recruiting, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Vascular Neoplasms: new trials by email Literature Review of Vascular Neoplasms trials Research Report on Vascular Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of a Simple-Prep Controlled Embolic GPX® Embolic Device - Embolization, Vascular Tumor | Not applicable | Active not recruiting | Fluidx Medical Technology, Inc. | 114 | 2024-11-18 | 2026-03-30 |
| Hepatic Small Vessel Neoplasm Imaging - Hepatic Small Vessel Neoplasm | Unknown | Assistance Publique - Hôpitaux de Paris | 20 | 2023-10-01 | 2023-10-04 | |
| Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma Retinal Hemangioblastoma, Von Hippel-Lindau Disease | Completed | National Eye Institute (NEI) | 25 | 2020-07-02 | 2026-06-10 | |
| A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology Haemoblock, Placebo - Vascular Diseases, Vascular Malformation | Phase 4 | Completed | Center for Vascular Pathology, Moscow | 200 | 2020-01-01 | 2021-11-04 |
| Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes Durvalumab, Tremelimumab - Advanced and/or Metastatic Sarcoma | Phase 2 | Completed | M.D. Anderson Cancer Center | 57 | 2016-08-16 | 2025-06-12 |
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic Laboratory Biomarker Analysis, Pembrolizumab, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Carcinoma of Unknown Primary | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 157 | 2016-08-15 | 2026-07-17 |
Carcinoma, Renal Cell (2) · Adrenal Cortex Neoplasms (1) · Angiomyolipoma (1) · Bone Neoplasms (1) · Capillary Malformation-Arteriovenous Malformation (1) · Capillary Malformations, Congenital, 1 (1) · Carcinoma, Small Cell (1) · Hemangioendothelioma, Epithelioid (1) · Hemangiosarcoma (1) · Histiocytoma, Malignant Fibrous (1) · Leiomyosarcoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Neoplasms, Unknown Primary (1)
Cardiovascular Diseases (6) · Neoplasms by Site (6) · Soft Tissue Neoplasms (6) · Neoplasms (5) · Vascular Diseases (5) · Neoplasms by Histologic Type (4) · Adenocarcinoma (2) · Angiomatosis (2) · Carcinoma (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hemangioma (2) · Kidney Diseases (2)
X-Rays (1) · durvalumab (1) · pembrolizumab (1) · tremelimumab (1)
M.D. Anderson Cancer Center (2) · Assistance Publique - Hôpitaux de Paris (1) · Center for Vascular Pathology, Moscow (1) · Fluidx Medical Technology, Inc. (1) · National Eye Institute (NEI) (1)
United States (4) · Canada (1) · New Zealand (1) · Russia (1)
Alexander Plotkin, PhD (1) · Aung Naing (1) · Dmitry V Romanov, MD (1) · Ekaterina M Listovskaya, BSc (1) · Emily Y Chew, M.D. (1) · Michael Darcy, MD (1) · Neeta Somaiah, MBBS (1)
PMID 31533818, PMID 32188704, PMID 32303619, PMID 32534809, PMID 33415580, PMID 33427689, PMID 33491277, PMID 33770291, PMID 34241781, PMID 34725215, PMID 35618285, PMID 35934010, PMID 35999229, PMID 37568622, PMID 40212844, PMID 41143139, PMID 42342409